CTI BioPharma Corp.
(NASDAQ : CTIC)

( )
CTIC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOThe Medicines Co.
-0.05%84.0320.1%$620.21m
AMRNAmarin Corp. Plc
0.79%22.991.7%$274.97m
VRXValeant Pharmaceuticals International, Inc.
8.71%31.8914.1%$187.65m
ARQLArQule, Inc.
-1.04%19.990.6%$140.34m
BHCBausch Health Cos., Inc.
8.71%31.890.0%$132.19m
SAGESAGE Therapeutics, Inc.
5.71%72.598.6%$129.22m
ICPTIntercept Pharmaceuticals, Inc.
-2.87%115.9316.9%$94.12m
JAZZJazz Pharmaceuticals Plc
1.20%149.902.3%$91.82m
GWPHGW Pharmaceuticals Plc
2.74%105.706.2%$86.29m
PRGOPerrigo Co. Plc
1.36%54.546.8%$65.30m
AXSMAxsome Therapeutics, Inc.
1.04%48.572.0%$60.26m
HZNPHorizon Therapeutics Plc
1.83%32.846.6%$44.72m
ICLRICON plc
-0.10%161.574.2%$42.46m
UTHRUnited Therapeutics Corp.
1.37%93.7614.3%$36.17m
ENDPEndo International Plc
7.06%4.708.8%$33.53m

Company Profile

CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.